WHWK
Whitehawk Therapeutics Inc
$3.51
%
Analyst Rating:N/A

Stock Details

CEO

David J. Lennon

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

40

Address

17383 Sunset Blvd, Suite A250, Pacific Palisades, CA, 90272

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Whitehawk Therapeutics Inc  $3.51

EPS

Revenue

Congress Tracker 

Insider Trading of Key Employees

Financial News: WHWK